VITAPHIL DHA beta carotene, ascorbic acid, cholecalciferol, alpha-tocopherol, thiamine hydrochloride, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, cyanocobalamin, biotin, calcium pantothenate, calcium carbonate, iron, magnesium oxide, zinc oxide, selenium, cupric oxide, choline bitartrate, doconexent kit |
| Product Information | | Product Type | HUMAN PRESCRIPTION DRUG LABEL | Item Code (Source) | NDC:68032-341 | |
| Packaging | | # | Item Code | Package Description | | 1 | NDC:68032-341-60 | 1 KIT (KIT) in 1 CARTON | |
| Quantity of Parts | | Part # | Package Quantity | Total Product Quantity | | Part 1 | 1 BOTTLE | 30 | | Part 2 | 1 BOTTLE | 30 | |
| Part 1 of 2 | VITAPHIL beta carotene, ascorbic acid, cholecalciferol, alpha-tocopherol, thiamine hydrochloride, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, cyanocobalamin, biotin, calcium pantothenate, calcium carbonate, iron, magnesium oxide, zinc oxide, selenium, cupric oxide, choline bitartrate tablet | |
| Product Information | | Item Code (Source) | NDC:68032-496 | | Route of Administration | ORAL | DEA Schedule | | |
| Active Ingredient/Active Moiety | | Ingredient Name | Basis of Strength | Strength | | BETA CAROTENE (BETA CAROTENE) | BETA CAROTENE | 2600 [iU] | | ASCORBIC ACID (ASCORBIC ACID) | ASCORBIC ACID | 120 mg | | CHOLECALCIFEROL (CHOLECALCIFEROL) | CHOLECALCIFEROL | 420 [iU] | | ALPHA-TOCOPHEROL (ALPHA-TOCOPHEROL) | ALPHA-TOCOPHEROL | 20 [iU] | | THIAMINE HYDROCHLORIDE (THIAMINE) | THIAMINE HYDROCHLORIDE | 3 mg | | RIBOFLAVIN (RIBOFLAVIN) | RIBOFLAVIN | 3.5 mg | | NIACINAMIDE (NIACINAMIDE) | NIACINAMIDE | 20 mg | | PYRIDOXINE HYDROCHLORIDE (PYRIDOXINE) | PYRIDOXINE HYDROCHLORIDE | 30 mg | | FOLIC ACID (FOLIC ACID) | FOLIC ACID | 1 mg | | CYANOCOBALAMIN (CYANOCOBALAMIN) | CYANOCOBALAMIN | 12 ug | | BIOTIN (BIOTIN) | BIOTIN | 30 ug | | CALCIUM PANTOTHENATE (CALCIUM) | CALCIUM PANTOTHENATE | 8 mg | | CALCIUM CARBONATE (CALCIUM) | CALCIUM CARBONATE | 100 mg | | IRON (IRON) | IRON | 26 mg | | MAGNESIUM OXIDE (MAGNESIUM OXIDE) | MAGNESIUM OXIDE | 50 mg | | ZINC OXIDE (ZINC) | ZINC OXIDE | 15 mg | | SELENIUM (SELENIUM) | SELENIUM | 50 ug | | CUPRIC OXIDE (COPPER) | CUPRIC OXIDE | 2 mg | | CHOLINE BITARTRATE (CHOLINE) | CHOLINE BITARTRATE | 60 mg | |
| Inactive Ingredients | | Ingredient Name | Strength | | CELLULOSE, MICROCRYSTALLINE | | | CROSCARMELLOSE SODIUM | | | CROSPOVIDONE | | | SILICON DIOXIDE | | | MAGNESIUM STEARATE | | | STEARIC ACID | | | MALTODEXTRIN | | | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | | | SODIUM ALGINATE | | | HYPROMELLOSE 2208 (100 MPA.S) | | | POLYETHYLENE GLYCOL | | | SUCROSE | | | GELATIN | | | STARCH, CORN | | | ACACIA | | | ALPHA-TOCOPHEROL, DL- | | | SOYBEAN OIL | | | TRIACETIN | | | TITANIUM DIOXIDE | | | FD&C BLUE NO. 1 | | | FD&C YELLOW NO. 5 | | | POLYSORBATE 80 | | |
| Product Characteristics | | Color | green | Score | no score | | Shape | CAPSULE | Size | 20mm | | Flavor | | Imprint Code | RE;341 | | Contains | | |
| Packaging | | # | Item Code | Package Description | | 1 | NDC:68032-496-30 | 30 TABLET (TABLET) in 1 BOTTLE | |
|
| Marketing Information | | Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date | | unapproved drug other | | 11/14/2008 | 12/31/2011 | |
| Part 2 of 2 | VITAPHIL DHA doconexent capsule, liquid filled | |
| Product Information | | Item Code (Source) | NDC:68032-497 | | Route of Administration | ORAL | DEA Schedule | | |
| Active Ingredient/Active Moiety | | Ingredient Name | Basis of Strength | Strength | | DOCONEXENT (DOCONEXENT) | DOCONEXENT | 200 mg | |
| Inactive Ingredients | | Ingredient Name | Strength | | GELATIN | | | WATER | | | GLYCERIN | | | POLYSORBATE 80 | | |
| Product Characteristics | | Color | yellow (Pale Yellow) | Score | no score | | Shape | CAPSULE | Size | 20mm | | Flavor | | Imprint Code | RE;499 | | Contains | | |
| Packaging | | # | Item Code | Package Description | | 1 | NDC:68032-497-30 | 30 CAPSULE, LIQUID FILLED (CAPSULE) in 1 BOTTLE | |
|
| Marketing Information | | Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date | | unapproved drug other | | 11/14/2008 | 12/31/2011 | |
|
| Marketing Information | | Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date | | unapproved drug other | | 11/14/2008 | 12/31/2011 | |